A South African group has generated the ZiBiPen, that provides a shot of adrenaline by a more sustainable, $16 cost. The reusable pen costs $80 and will be meant to last five decades.
A group of South African engineers have assembled an inexpensive substitute for the EpiPen which may reevaluate the emergency treatment for anaphylaxis, a severe allergic reaction which could be triggered by food or insect bites.
“The cost of the pen is $80 and we are testing to make it last up to five years,” said Gokul Nair, that helped build it together with fellow University of Cape Town’s Medical Devices Laboratory alumnus Giancarlo Beukes.
That’s a fraction of the price of the dominant apparatus available on the current marketplace, the EpiPen, that retails for $600 at a bunch of two; lasts up to 18 weeks; and may only be used once.
“When we originally did research into the cost of the devices on the market, we found that delays in the distribution chain can mean South Africans only receive their devices with six months before expiry, which made it unaffordable for South Africans,” said Nair, who initially made it to get a master’s job in the Department of Asthma and Allergy in the Red Cross Children’s Hospital.
The climbing cost of this EpiPen has witnessed that a class action litigation against manufacturer Mylan. The lawsuit claims the business is engaged in an illegal scheme to radically boost the listing price, which ten years back was 88$, reported CNBC.
Adrenaline auto-injectors are added into the thigh, through the clothing. The shot reduces the allergic response, buying valuable time to get customers to your hospital.
